See what makes a FRACTION study unique 2:54
Thank You for Considering a Clinical Trial
Everyone's cancer is different. A study drug combination that works well for some may not work as well for others.
Bristol-Myers Squibb created an innovative clinical trial plan that allows each person who takes part to receive different treatment options, depending on their individual response to the study drugs.
That means, if the first study treatment option that is assigned to you works, that's great! You'll continue with that study treatment. But, if the study treatment option doesn't work well, you may be able to try another study treatment option. We call this clinical trial plan FRACTION.
Below you will find three clinical trials that are currently recruiting patients in Lung Cancer, Gastric Cancer and Renal Cell Carcinoma.
Here's what to do next
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
View Trial DetailsA Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
View Trial DetailsA Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
View Trial DetailsPlease note, not all studies may be enrolling at this time. Check back often for updates.
